nodes	percent_of_prediction	percent_of_DWPC	metapath
Zolpidem—CYP1A2—Anagrelide—hematologic cancer	0.0232	0.035	CbGbCtD
Zolpidem—PTGS1—Bortezomib—hematologic cancer	0.0221	0.0333	CbGbCtD
Zolpidem—PTGS1—Thalidomide—hematologic cancer	0.0192	0.029	CbGbCtD
Zolpidem—PTGS1—Ifosfamide—hematologic cancer	0.0169	0.0256	CbGbCtD
Zolpidem—PTGS1—Imatinib—hematologic cancer	0.0162	0.0244	CbGbCtD
Zolpidem—CYP2C9—Bexarotene—hematologic cancer	0.0145	0.0219	CbGbCtD
Zolpidem—CYP3A7—Ifosfamide—hematologic cancer	0.0135	0.0204	CbGbCtD
Zolpidem—CYP3A7-CYP3A51P—Ifosfamide—hematologic cancer	0.0135	0.0204	CbGbCtD
Zolpidem—CYP3A7—Imatinib—hematologic cancer	0.0129	0.0195	CbGbCtD
Zolpidem—CYP3A7-CYP3A51P—Imatinib—hematologic cancer	0.0129	0.0195	CbGbCtD
Zolpidem—CYP3A5—Daunorubicin—hematologic cancer	0.0127	0.0191	CbGbCtD
Zolpidem—CYP2D6—Lomustine—hematologic cancer	0.0123	0.0186	CbGbCtD
Zolpidem—CYP1A2—Carmustine—hematologic cancer	0.0122	0.0184	CbGbCtD
Zolpidem—CYP2C9—Idarubicin—hematologic cancer	0.012	0.0181	CbGbCtD
Zolpidem—CYP3A5—Thalidomide—hematologic cancer	0.0115	0.0174	CbGbCtD
Zolpidem—CYP3A5—Teniposide—hematologic cancer	0.011	0.0166	CbGbCtD
Zolpidem—CYP2D6—Idarubicin—hematologic cancer	0.011	0.0166	CbGbCtD
Zolpidem—CYP2C19—Bortezomib—hematologic cancer	0.0107	0.0161	CbGbCtD
Zolpidem—CYP1A2—Methoxsalen—hematologic cancer	0.0104	0.0156	CbGbCtD
Zolpidem—CYP3A5—Ifosfamide—hematologic cancer	0.0102	0.0153	CbGbCtD
Zolpidem—CYP1A2—Bortezomib—hematologic cancer	0.00986	0.0149	CbGbCtD
Zolpidem—CYP3A5—Imatinib—hematologic cancer	0.00971	0.0147	CbGbCtD
Zolpidem—CYP1A2—Daunorubicin—hematologic cancer	0.00943	0.0142	CbGbCtD
Zolpidem—CYP2D6—Hydroxyurea—hematologic cancer	0.00934	0.0141	CbGbCtD
Zolpidem—CYP2C19—Thalidomide—hematologic cancer	0.00931	0.0141	CbGbCtD
Zolpidem—CYP1A2—Alitretinoin—hematologic cancer	0.00924	0.0139	CbGbCtD
Zolpidem—CYP2C9—Bortezomib—hematologic cancer	0.00888	0.0134	CbGbCtD
Zolpidem—CYP2C19—Teniposide—hematologic cancer	0.00888	0.0134	CbGbCtD
Zolpidem—CYP1A2—Thalidomide—hematologic cancer	0.00859	0.013	CbGbCtD
Zolpidem—CYP3A4—Bexarotene—hematologic cancer	0.00843	0.0127	CbGbCtD
Zolpidem—CYP2C19—Ifosfamide—hematologic cancer	0.00819	0.0124	CbGbCtD
Zolpidem—CYP2D6—Bortezomib—hematologic cancer	0.00812	0.0123	CbGbCtD
Zolpidem—PTGS1—Etoposide—hematologic cancer	0.00809	0.0122	CbGbCtD
Zolpidem—CYP3A7—Irinotecan—hematologic cancer	0.00808	0.0122	CbGbCtD
Zolpidem—CYP3A7-CYP3A51P—Irinotecan—hematologic cancer	0.00808	0.0122	CbGbCtD
Zolpidem—CYP3A4—Busulfan—hematologic cancer	0.00783	0.0118	CbGbCtD
Zolpidem—CYP3A4—Lomustine—hematologic cancer	0.00783	0.0118	CbGbCtD
Zolpidem—CYP2C19—Imatinib—hematologic cancer	0.00783	0.0118	CbGbCtD
Zolpidem—CYP3A5—Dasatinib—hematologic cancer	0.00779	0.0118	CbGbCtD
Zolpidem—CYP2C9—Thalidomide—hematologic cancer	0.00774	0.0117	CbGbCtD
Zolpidem—CYP1A2—Dacarbazine—hematologic cancer	0.00739	0.0111	CbGbCtD
Zolpidem—CYP2C9—Teniposide—hematologic cancer	0.00738	0.0111	CbGbCtD
Zolpidem—CYP1A2—Imatinib—hematologic cancer	0.00722	0.0109	CbGbCtD
Zolpidem—CYP3A7—Vincristine—hematologic cancer	0.00706	0.0107	CbGbCtD
Zolpidem—CYP3A7-CYP3A51P—Vincristine—hematologic cancer	0.00706	0.0107	CbGbCtD
Zolpidem—CYP3A4—Thiotepa—hematologic cancer	0.00698	0.0105	CbGbCtD
Zolpidem—CYP2C9—Ifosfamide—hematologic cancer	0.00681	0.0103	CbGbCtD
Zolpidem—CYP2C9—Imatinib—hematologic cancer	0.00651	0.00983	CbGbCtD
Zolpidem—CYP3A5—Irinotecan—hematologic cancer	0.00606	0.00915	CbGbCtD
Zolpidem—CYP2D6—Imatinib—hematologic cancer	0.00595	0.00898	CbGbCtD
Zolpidem—CYP2C9—Nilotinib—hematologic cancer	0.00591	0.00893	CbGbCtD
Zolpidem—CYP1A2—Dasatinib—hematologic cancer	0.0058	0.00876	CbGbCtD
Zolpidem—CYP3A4—Methoxsalen—hematologic cancer	0.00543	0.0082	CbGbCtD
Zolpidem—CYP2D6—Nilotinib—hematologic cancer	0.00541	0.00816	CbGbCtD
Zolpidem—CYP2D6—Vinorelbine—hematologic cancer	0.00536	0.0081	CbGbCtD
Zolpidem—CYP3A7-CYP3A51P—Dexamethasone—hematologic cancer	0.00532	0.00803	CbGbCtD
Zolpidem—CYP3A7—Dexamethasone—hematologic cancer	0.00532	0.00803	CbGbCtD
Zolpidem—CYP3A5—Vincristine—hematologic cancer	0.0053	0.008	CbGbCtD
Zolpidem—CYP3A4—Bortezomib—hematologic cancer	0.00517	0.0078	CbGbCtD
Zolpidem—CYP2C19—Prednisone—hematologic cancer	0.00516	0.00779	CbGbCtD
Zolpidem—CYP3A4—Daunorubicin—hematologic cancer	0.00494	0.00746	CbGbCtD
Zolpidem—CYP3A5—Etoposide—hematologic cancer	0.00486	0.00733	CbGbCtD
Zolpidem—CYP3A4—Cytarabine—hematologic cancer	0.00436	0.00658	CbGbCtD
Zolpidem—CYP3A4—Teniposide—hematologic cancer	0.00429	0.00648	CbGbCtD
Zolpidem—CYP3A5—Dexamethasone—hematologic cancer	0.00399	0.00603	CbGbCtD
Zolpidem—CYP3A4—Ifosfamide—hematologic cancer	0.00396	0.00598	CbGbCtD
Zolpidem—CYP3A4—Imatinib—hematologic cancer	0.00378	0.00571	CbGbCtD
Zolpidem—CYP1A2—Etoposide—hematologic cancer	0.00361	0.00546	CbGbCtD
Zolpidem—CYP3A4—Ruxolitinib—hematologic cancer	0.00356	0.00538	CbGbCtD
Zolpidem—CYP3A4—Nilotinib—hematologic cancer	0.00344	0.00519	CbGbCtD
Zolpidem—CYP3A4—Vinorelbine—hematologic cancer	0.00341	0.00515	CbGbCtD
Zolpidem—CYP2C9—Cisplatin—hematologic cancer	0.00331	0.005	CbGbCtD
Zolpidem—CYP2D6—Vinblastine—hematologic cancer	0.00331	0.00499	CbGbCtD
Zolpidem—CYP2C19—Dexamethasone—hematologic cancer	0.00322	0.00486	CbGbCtD
Zolpidem—CYP3A4—Triamcinolone—hematologic cancer	0.00312	0.00471	CbGbCtD
Zolpidem—CYP3A4—Dasatinib—hematologic cancer	0.00304	0.00459	CbGbCtD
Zolpidem—CYP3A4—Mitoxantrone—hematologic cancer	0.003	0.00453	CbGbCtD
Zolpidem—CYP2C9—Dexamethasone—hematologic cancer	0.00268	0.00404	CbGbCtD
Zolpidem—CYP3A4—Betamethasone—hematologic cancer	0.00268	0.00404	CbGbCtD
Zolpidem—CYP3A4—Prednisolone—hematologic cancer	0.00264	0.00399	CbGbCtD
Zolpidem—CYP3A4—Prednisone—hematologic cancer	0.00249	0.00376	CbGbCtD
Zolpidem—CYP2D6—Dexamethasone—hematologic cancer	0.00245	0.0037	CbGbCtD
Zolpidem—CYP3A4—Irinotecan—hematologic cancer	0.00236	0.00357	CbGbCtD
Zolpidem—CYP3A4—Vinblastine—hematologic cancer	0.0021	0.00317	CbGbCtD
Zolpidem—CYP3A4—Vincristine—hematologic cancer	0.00207	0.00312	CbGbCtD
Zolpidem—CYP2D6—Doxorubicin—hematologic cancer	0.00203	0.00307	CbGbCtD
Zolpidem—CYP3A4—Etoposide—hematologic cancer	0.00189	0.00286	CbGbCtD
Zolpidem—CYP3A4—Dexamethasone—hematologic cancer	0.00156	0.00235	CbGbCtD
Zolpidem—CYP3A4—Doxorubicin—hematologic cancer	0.00129	0.00195	CbGbCtD
Zolpidem—Tolmetin—MPO—hematologic cancer	0.00124	1	CrCbGaD
Zolpidem—Anorexia—Prednisone—hematologic cancer	1.88e-05	6.6e-05	CcSEcCtD
Zolpidem—Eye disorder—Doxorubicin—hematologic cancer	1.88e-05	6.59e-05	CcSEcCtD
Zolpidem—Ill-defined disorder—Methotrexate—hematologic cancer	1.88e-05	6.57e-05	CcSEcCtD
Zolpidem—Tinnitus—Doxorubicin—hematologic cancer	1.88e-05	6.57e-05	CcSEcCtD
Zolpidem—Anaemia—Methotrexate—hematologic cancer	1.87e-05	6.55e-05	CcSEcCtD
Zolpidem—Feeling abnormal—Betamethasone—hematologic cancer	1.87e-05	6.55e-05	CcSEcCtD
Zolpidem—Feeling abnormal—Dexamethasone—hematologic cancer	1.87e-05	6.55e-05	CcSEcCtD
Zolpidem—Cardiac disorder—Doxorubicin—hematologic cancer	1.87e-05	6.54e-05	CcSEcCtD
Zolpidem—Flushing—Doxorubicin—hematologic cancer	1.87e-05	6.54e-05	CcSEcCtD
Zolpidem—Flatulence—Epirubicin—hematologic cancer	1.87e-05	6.53e-05	CcSEcCtD
Zolpidem—Tension—Epirubicin—hematologic cancer	1.86e-05	6.51e-05	CcSEcCtD
Zolpidem—Gastrointestinal pain—Dexamethasone—hematologic cancer	1.86e-05	6.5e-05	CcSEcCtD
Zolpidem—Gastrointestinal pain—Betamethasone—hematologic cancer	1.86e-05	6.5e-05	CcSEcCtD
Zolpidem—Dysgeusia—Epirubicin—hematologic cancer	1.86e-05	6.49e-05	CcSEcCtD
Zolpidem—Hypersensitivity—Triamcinolone—hematologic cancer	1.84e-05	6.45e-05	CcSEcCtD
Zolpidem—Nervousness—Epirubicin—hematologic cancer	1.84e-05	6.44e-05	CcSEcCtD
Zolpidem—Back pain—Epirubicin—hematologic cancer	1.83e-05	6.41e-05	CcSEcCtD
Zolpidem—Malaise—Methotrexate—hematologic cancer	1.83e-05	6.39e-05	CcSEcCtD
Zolpidem—Dizziness—Etoposide—hematologic cancer	1.82e-05	6.38e-05	CcSEcCtD
Zolpidem—Muscle spasms—Epirubicin—hematologic cancer	1.82e-05	6.38e-05	CcSEcCtD
Zolpidem—Vertigo—Methotrexate—hematologic cancer	1.82e-05	6.37e-05	CcSEcCtD
Zolpidem—Mediastinal disorder—Doxorubicin—hematologic cancer	1.81e-05	6.35e-05	CcSEcCtD
Zolpidem—Leukopenia—Methotrexate—hematologic cancer	1.81e-05	6.34e-05	CcSEcCtD
Zolpidem—Chills—Doxorubicin—hematologic cancer	1.81e-05	6.32e-05	CcSEcCtD
Zolpidem—Urticaria—Dexamethasone—hematologic cancer	1.8e-05	6.31e-05	CcSEcCtD
Zolpidem—Urticaria—Betamethasone—hematologic cancer	1.8e-05	6.31e-05	CcSEcCtD
Zolpidem—Musculoskeletal discomfort—Prednisone—hematologic cancer	1.8e-05	6.3e-05	CcSEcCtD
Zolpidem—Dizziness—Prednisolone—hematologic cancer	1.8e-05	6.3e-05	CcSEcCtD
Zolpidem—Arrhythmia—Doxorubicin—hematologic cancer	1.8e-05	6.3e-05	CcSEcCtD
Zolpidem—Asthenia—Triamcinolone—hematologic cancer	1.79e-05	6.28e-05	CcSEcCtD
Zolpidem—Body temperature increased—Dexamethasone—hematologic cancer	1.79e-05	6.28e-05	CcSEcCtD
Zolpidem—Abdominal pain—Betamethasone—hematologic cancer	1.79e-05	6.28e-05	CcSEcCtD
Zolpidem—Abdominal pain—Dexamethasone—hematologic cancer	1.79e-05	6.28e-05	CcSEcCtD
Zolpidem—Body temperature increased—Betamethasone—hematologic cancer	1.79e-05	6.28e-05	CcSEcCtD
Zolpidem—Nausea—Cisplatin—hematologic cancer	1.79e-05	6.26e-05	CcSEcCtD
Zolpidem—Insomnia—Prednisone—hematologic cancer	1.79e-05	6.26e-05	CcSEcCtD
Zolpidem—Vision blurred—Epirubicin—hematologic cancer	1.79e-05	6.25e-05	CcSEcCtD
Zolpidem—Paraesthesia—Prednisone—hematologic cancer	1.78e-05	6.21e-05	CcSEcCtD
Zolpidem—Pruritus—Triamcinolone—hematologic cancer	1.77e-05	6.2e-05	CcSEcCtD
Zolpidem—Cough—Methotrexate—hematologic cancer	1.77e-05	6.18e-05	CcSEcCtD
Zolpidem—Mental disorder—Doxorubicin—hematologic cancer	1.76e-05	6.17e-05	CcSEcCtD
Zolpidem—Ill-defined disorder—Epirubicin—hematologic cancer	1.76e-05	6.15e-05	CcSEcCtD
Zolpidem—Vomiting—Etoposide—hematologic cancer	1.75e-05	6.14e-05	CcSEcCtD
Zolpidem—Erythema—Doxorubicin—hematologic cancer	1.75e-05	6.14e-05	CcSEcCtD
Zolpidem—Malnutrition—Doxorubicin—hematologic cancer	1.75e-05	6.14e-05	CcSEcCtD
Zolpidem—Anaemia—Epirubicin—hematologic cancer	1.75e-05	6.13e-05	CcSEcCtD
Zolpidem—Agitation—Epirubicin—hematologic cancer	1.74e-05	6.09e-05	CcSEcCtD
Zolpidem—Dyspepsia—Prednisone—hematologic cancer	1.74e-05	6.09e-05	CcSEcCtD
Zolpidem—Rash—Etoposide—hematologic cancer	1.74e-05	6.09e-05	CcSEcCtD
Zolpidem—Dermatitis—Etoposide—hematologic cancer	1.74e-05	6.08e-05	CcSEcCtD
Zolpidem—Headache—Etoposide—hematologic cancer	1.73e-05	6.05e-05	CcSEcCtD
Zolpidem—Flatulence—Doxorubicin—hematologic cancer	1.73e-05	6.05e-05	CcSEcCtD
Zolpidem—Arthralgia—Methotrexate—hematologic cancer	1.72e-05	6.03e-05	CcSEcCtD
Zolpidem—Chest pain—Methotrexate—hematologic cancer	1.72e-05	6.03e-05	CcSEcCtD
Zolpidem—Myalgia—Methotrexate—hematologic cancer	1.72e-05	6.03e-05	CcSEcCtD
Zolpidem—Tension—Doxorubicin—hematologic cancer	1.72e-05	6.02e-05	CcSEcCtD
Zolpidem—Decreased appetite—Prednisone—hematologic cancer	1.72e-05	6.01e-05	CcSEcCtD
Zolpidem—Dysgeusia—Doxorubicin—hematologic cancer	1.72e-05	6.01e-05	CcSEcCtD
Zolpidem—Rash—Prednisolone—hematologic cancer	1.72e-05	6e-05	CcSEcCtD
Zolpidem—Dermatitis—Prednisolone—hematologic cancer	1.71e-05	6e-05	CcSEcCtD
Zolpidem—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	1.71e-05	5.99e-05	CcSEcCtD
Zolpidem—Malaise—Epirubicin—hematologic cancer	1.71e-05	5.98e-05	CcSEcCtD
Zolpidem—Fatigue—Prednisone—hematologic cancer	1.7e-05	5.97e-05	CcSEcCtD
Zolpidem—Headache—Prednisolone—hematologic cancer	1.7e-05	5.97e-05	CcSEcCtD
Zolpidem—Discomfort—Methotrexate—hematologic cancer	1.7e-05	5.96e-05	CcSEcCtD
Zolpidem—Nervousness—Doxorubicin—hematologic cancer	1.7e-05	5.96e-05	CcSEcCtD
Zolpidem—Vertigo—Epirubicin—hematologic cancer	1.7e-05	5.96e-05	CcSEcCtD
Zolpidem—Syncope—Epirubicin—hematologic cancer	1.7e-05	5.95e-05	CcSEcCtD
Zolpidem—Leukopenia—Epirubicin—hematologic cancer	1.7e-05	5.94e-05	CcSEcCtD
Zolpidem—Back pain—Doxorubicin—hematologic cancer	1.7e-05	5.93e-05	CcSEcCtD
Zolpidem—Constipation—Prednisone—hematologic cancer	1.69e-05	5.92e-05	CcSEcCtD
Zolpidem—Muscle spasms—Doxorubicin—hematologic cancer	1.69e-05	5.9e-05	CcSEcCtD
Zolpidem—Palpitations—Epirubicin—hematologic cancer	1.67e-05	5.86e-05	CcSEcCtD
Zolpidem—Confusional state—Methotrexate—hematologic cancer	1.67e-05	5.83e-05	CcSEcCtD
Zolpidem—Loss of consciousness—Epirubicin—hematologic cancer	1.66e-05	5.83e-05	CcSEcCtD
Zolpidem—Dizziness—Triamcinolone—hematologic cancer	1.65e-05	5.79e-05	CcSEcCtD
Zolpidem—Cough—Epirubicin—hematologic cancer	1.65e-05	5.79e-05	CcSEcCtD
Zolpidem—Anaphylactic shock—Methotrexate—hematologic cancer	1.65e-05	5.78e-05	CcSEcCtD
Zolpidem—Vision blurred—Doxorubicin—hematologic cancer	1.65e-05	5.78e-05	CcSEcCtD
Zolpidem—Infection—Methotrexate—hematologic cancer	1.64e-05	5.74e-05	CcSEcCtD
Zolpidem—Nausea—Etoposide—hematologic cancer	1.64e-05	5.73e-05	CcSEcCtD
Zolpidem—Hypertension—Epirubicin—hematologic cancer	1.64e-05	5.72e-05	CcSEcCtD
Zolpidem—Feeling abnormal—Prednisone—hematologic cancer	1.63e-05	5.7e-05	CcSEcCtD
Zolpidem—Asthenia—Dexamethasone—hematologic cancer	1.63e-05	5.7e-05	CcSEcCtD
Zolpidem—Asthenia—Betamethasone—hematologic cancer	1.63e-05	5.7e-05	CcSEcCtD
Zolpidem—Ill-defined disorder—Doxorubicin—hematologic cancer	1.63e-05	5.69e-05	CcSEcCtD
Zolpidem—Nervous system disorder—Methotrexate—hematologic cancer	1.62e-05	5.67e-05	CcSEcCtD
Zolpidem—Anaemia—Doxorubicin—hematologic cancer	1.62e-05	5.67e-05	CcSEcCtD
Zolpidem—Gastrointestinal pain—Prednisone—hematologic cancer	1.62e-05	5.66e-05	CcSEcCtD
Zolpidem—Nausea—Prednisolone—hematologic cancer	1.62e-05	5.66e-05	CcSEcCtD
Zolpidem—Arthralgia—Epirubicin—hematologic cancer	1.61e-05	5.65e-05	CcSEcCtD
Zolpidem—Chest pain—Epirubicin—hematologic cancer	1.61e-05	5.65e-05	CcSEcCtD
Zolpidem—Myalgia—Epirubicin—hematologic cancer	1.61e-05	5.65e-05	CcSEcCtD
Zolpidem—Agitation—Doxorubicin—hematologic cancer	1.61e-05	5.64e-05	CcSEcCtD
Zolpidem—Anxiety—Epirubicin—hematologic cancer	1.61e-05	5.63e-05	CcSEcCtD
Zolpidem—Pruritus—Betamethasone—hematologic cancer	1.61e-05	5.62e-05	CcSEcCtD
Zolpidem—Pruritus—Dexamethasone—hematologic cancer	1.61e-05	5.62e-05	CcSEcCtD
Zolpidem—Skin disorder—Methotrexate—hematologic cancer	1.6e-05	5.62e-05	CcSEcCtD
Zolpidem—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	1.6e-05	5.61e-05	CcSEcCtD
Zolpidem—Hyperhidrosis—Methotrexate—hematologic cancer	1.6e-05	5.59e-05	CcSEcCtD
Zolpidem—Discomfort—Epirubicin—hematologic cancer	1.59e-05	5.58e-05	CcSEcCtD
Zolpidem—Vomiting—Triamcinolone—hematologic cancer	1.59e-05	5.57e-05	CcSEcCtD
Zolpidem—Malaise—Doxorubicin—hematologic cancer	1.58e-05	5.53e-05	CcSEcCtD
Zolpidem—Rash—Triamcinolone—hematologic cancer	1.58e-05	5.52e-05	CcSEcCtD
Zolpidem—Dry mouth—Epirubicin—hematologic cancer	1.58e-05	5.52e-05	CcSEcCtD
Zolpidem—Dermatitis—Triamcinolone—hematologic cancer	1.58e-05	5.52e-05	CcSEcCtD
Zolpidem—Vertigo—Doxorubicin—hematologic cancer	1.57e-05	5.51e-05	CcSEcCtD
Zolpidem—Anorexia—Methotrexate—hematologic cancer	1.57e-05	5.51e-05	CcSEcCtD
Zolpidem—Syncope—Doxorubicin—hematologic cancer	1.57e-05	5.5e-05	CcSEcCtD
Zolpidem—Urticaria—Prednisone—hematologic cancer	1.57e-05	5.5e-05	CcSEcCtD
Zolpidem—Leukopenia—Doxorubicin—hematologic cancer	1.57e-05	5.49e-05	CcSEcCtD
Zolpidem—Headache—Triamcinolone—hematologic cancer	1.57e-05	5.49e-05	CcSEcCtD
Zolpidem—Abdominal pain—Prednisone—hematologic cancer	1.56e-05	5.47e-05	CcSEcCtD
Zolpidem—Body temperature increased—Prednisone—hematologic cancer	1.56e-05	5.47e-05	CcSEcCtD
Zolpidem—Confusional state—Epirubicin—hematologic cancer	1.56e-05	5.46e-05	CcSEcCtD
Zolpidem—Diarrhoea—Dexamethasone—hematologic cancer	1.55e-05	5.44e-05	CcSEcCtD
Zolpidem—Diarrhoea—Betamethasone—hematologic cancer	1.55e-05	5.44e-05	CcSEcCtD
Zolpidem—Palpitations—Doxorubicin—hematologic cancer	1.55e-05	5.42e-05	CcSEcCtD
Zolpidem—Anaphylactic shock—Epirubicin—hematologic cancer	1.55e-05	5.41e-05	CcSEcCtD
Zolpidem—Oedema—Epirubicin—hematologic cancer	1.55e-05	5.41e-05	CcSEcCtD
Zolpidem—Hypotension—Methotrexate—hematologic cancer	1.54e-05	5.4e-05	CcSEcCtD
Zolpidem—Loss of consciousness—Doxorubicin—hematologic cancer	1.54e-05	5.39e-05	CcSEcCtD
Zolpidem—Infection—Epirubicin—hematologic cancer	1.54e-05	5.38e-05	CcSEcCtD
Zolpidem—Cough—Doxorubicin—hematologic cancer	1.53e-05	5.35e-05	CcSEcCtD
Zolpidem—Shock—Epirubicin—hematologic cancer	1.52e-05	5.32e-05	CcSEcCtD
Zolpidem—Nervous system disorder—Epirubicin—hematologic cancer	1.52e-05	5.31e-05	CcSEcCtD
Zolpidem—Hypertension—Doxorubicin—hematologic cancer	1.51e-05	5.3e-05	CcSEcCtD
Zolpidem—Tachycardia—Epirubicin—hematologic cancer	1.51e-05	5.28e-05	CcSEcCtD
Zolpidem—Musculoskeletal discomfort—Methotrexate—hematologic cancer	1.51e-05	5.27e-05	CcSEcCtD
Zolpidem—Skin disorder—Epirubicin—hematologic cancer	1.5e-05	5.26e-05	CcSEcCtD
Zolpidem—Dizziness—Betamethasone—hematologic cancer	1.5e-05	5.25e-05	CcSEcCtD
Zolpidem—Dizziness—Dexamethasone—hematologic cancer	1.5e-05	5.25e-05	CcSEcCtD
Zolpidem—Hyperhidrosis—Epirubicin—hematologic cancer	1.49e-05	5.23e-05	CcSEcCtD
Zolpidem—Insomnia—Methotrexate—hematologic cancer	1.49e-05	5.23e-05	CcSEcCtD
Zolpidem—Chest pain—Doxorubicin—hematologic cancer	1.49e-05	5.22e-05	CcSEcCtD
Zolpidem—Arthralgia—Doxorubicin—hematologic cancer	1.49e-05	5.22e-05	CcSEcCtD
Zolpidem—Myalgia—Doxorubicin—hematologic cancer	1.49e-05	5.22e-05	CcSEcCtD
Zolpidem—Anxiety—Doxorubicin—hematologic cancer	1.49e-05	5.21e-05	CcSEcCtD
Zolpidem—Nausea—Triamcinolone—hematologic cancer	1.49e-05	5.2e-05	CcSEcCtD
Zolpidem—Paraesthesia—Methotrexate—hematologic cancer	1.48e-05	5.19e-05	CcSEcCtD
Zolpidem—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	1.48e-05	5.19e-05	CcSEcCtD
Zolpidem—Discomfort—Doxorubicin—hematologic cancer	1.47e-05	5.16e-05	CcSEcCtD
Zolpidem—Anorexia—Epirubicin—hematologic cancer	1.47e-05	5.16e-05	CcSEcCtD
Zolpidem—Dyspnoea—Methotrexate—hematologic cancer	1.47e-05	5.16e-05	CcSEcCtD
Zolpidem—Somnolence—Methotrexate—hematologic cancer	1.47e-05	5.14e-05	CcSEcCtD
Zolpidem—Dry mouth—Doxorubicin—hematologic cancer	1.46e-05	5.11e-05	CcSEcCtD
Zolpidem—Hypersensitivity—Prednisone—hematologic cancer	1.46e-05	5.1e-05	CcSEcCtD
Zolpidem—Dyspepsia—Methotrexate—hematologic cancer	1.45e-05	5.09e-05	CcSEcCtD
Zolpidem—Hypotension—Epirubicin—hematologic cancer	1.44e-05	5.06e-05	CcSEcCtD
Zolpidem—Vomiting—Betamethasone—hematologic cancer	1.44e-05	5.05e-05	CcSEcCtD
Zolpidem—Vomiting—Dexamethasone—hematologic cancer	1.44e-05	5.05e-05	CcSEcCtD
Zolpidem—Confusional state—Doxorubicin—hematologic cancer	1.44e-05	5.05e-05	CcSEcCtD
Zolpidem—Decreased appetite—Methotrexate—hematologic cancer	1.44e-05	5.03e-05	CcSEcCtD
Zolpidem—Rash—Betamethasone—hematologic cancer	1.43e-05	5.01e-05	CcSEcCtD
Zolpidem—Rash—Dexamethasone—hematologic cancer	1.43e-05	5.01e-05	CcSEcCtD
Zolpidem—Oedema—Doxorubicin—hematologic cancer	1.43e-05	5.01e-05	CcSEcCtD
Zolpidem—Anaphylactic shock—Doxorubicin—hematologic cancer	1.43e-05	5.01e-05	CcSEcCtD
Zolpidem—Dermatitis—Dexamethasone—hematologic cancer	1.43e-05	5.01e-05	CcSEcCtD
Zolpidem—Dermatitis—Betamethasone—hematologic cancer	1.43e-05	5.01e-05	CcSEcCtD
Zolpidem—Gastrointestinal disorder—Methotrexate—hematologic cancer	1.43e-05	4.99e-05	CcSEcCtD
Zolpidem—Fatigue—Methotrexate—hematologic cancer	1.42e-05	4.99e-05	CcSEcCtD
Zolpidem—Headache—Dexamethasone—hematologic cancer	1.42e-05	4.98e-05	CcSEcCtD
Zolpidem—Headache—Betamethasone—hematologic cancer	1.42e-05	4.98e-05	CcSEcCtD
Zolpidem—Infection—Doxorubicin—hematologic cancer	1.42e-05	4.97e-05	CcSEcCtD
Zolpidem—Asthenia—Prednisone—hematologic cancer	1.42e-05	4.96e-05	CcSEcCtD
Zolpidem—Pain—Methotrexate—hematologic cancer	1.41e-05	4.95e-05	CcSEcCtD
Zolpidem—Musculoskeletal discomfort—Epirubicin—hematologic cancer	1.41e-05	4.93e-05	CcSEcCtD
Zolpidem—Shock—Doxorubicin—hematologic cancer	1.41e-05	4.93e-05	CcSEcCtD
Zolpidem—Nervous system disorder—Doxorubicin—hematologic cancer	1.4e-05	4.91e-05	CcSEcCtD
Zolpidem—Pruritus—Prednisone—hematologic cancer	1.4e-05	4.9e-05	CcSEcCtD
Zolpidem—Insomnia—Epirubicin—hematologic cancer	1.4e-05	4.89e-05	CcSEcCtD
Zolpidem—Tachycardia—Doxorubicin—hematologic cancer	1.4e-05	4.89e-05	CcSEcCtD
Zolpidem—Skin disorder—Doxorubicin—hematologic cancer	1.39e-05	4.86e-05	CcSEcCtD
Zolpidem—Paraesthesia—Epirubicin—hematologic cancer	1.39e-05	4.86e-05	CcSEcCtD
Zolpidem—Hyperhidrosis—Doxorubicin—hematologic cancer	1.38e-05	4.84e-05	CcSEcCtD
Zolpidem—Dyspnoea—Epirubicin—hematologic cancer	1.38e-05	4.82e-05	CcSEcCtD
Zolpidem—Somnolence—Epirubicin—hematologic cancer	1.37e-05	4.81e-05	CcSEcCtD
Zolpidem—Anorexia—Doxorubicin—hematologic cancer	1.36e-05	4.77e-05	CcSEcCtD
Zolpidem—Feeling abnormal—Methotrexate—hematologic cancer	1.36e-05	4.77e-05	CcSEcCtD
Zolpidem—Dyspepsia—Epirubicin—hematologic cancer	1.36e-05	4.76e-05	CcSEcCtD
Zolpidem—Diarrhoea—Prednisone—hematologic cancer	1.35e-05	4.73e-05	CcSEcCtD
Zolpidem—Gastrointestinal pain—Methotrexate—hematologic cancer	1.35e-05	4.73e-05	CcSEcCtD
Zolpidem—Nausea—Betamethasone—hematologic cancer	1.35e-05	4.72e-05	CcSEcCtD
Zolpidem—Nausea—Dexamethasone—hematologic cancer	1.35e-05	4.72e-05	CcSEcCtD
Zolpidem—Decreased appetite—Epirubicin—hematologic cancer	1.34e-05	4.7e-05	CcSEcCtD
Zolpidem—Hypotension—Doxorubicin—hematologic cancer	1.34e-05	4.68e-05	CcSEcCtD
Zolpidem—Gastrointestinal disorder—Epirubicin—hematologic cancer	1.33e-05	4.67e-05	CcSEcCtD
Zolpidem—Fatigue—Epirubicin—hematologic cancer	1.33e-05	4.67e-05	CcSEcCtD
Zolpidem—Pain—Epirubicin—hematologic cancer	1.32e-05	4.63e-05	CcSEcCtD
Zolpidem—Constipation—Epirubicin—hematologic cancer	1.32e-05	4.63e-05	CcSEcCtD
Zolpidem—Urticaria—Methotrexate—hematologic cancer	1.31e-05	4.59e-05	CcSEcCtD
Zolpidem—Dizziness—Prednisone—hematologic cancer	1.31e-05	4.58e-05	CcSEcCtD
Zolpidem—Abdominal pain—Methotrexate—hematologic cancer	1.31e-05	4.57e-05	CcSEcCtD
Zolpidem—Body temperature increased—Methotrexate—hematologic cancer	1.31e-05	4.57e-05	CcSEcCtD
Zolpidem—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	1.3e-05	4.56e-05	CcSEcCtD
Zolpidem—Insomnia—Doxorubicin—hematologic cancer	1.29e-05	4.53e-05	CcSEcCtD
Zolpidem—Paraesthesia—Doxorubicin—hematologic cancer	1.28e-05	4.5e-05	CcSEcCtD
Zolpidem—Dyspnoea—Doxorubicin—hematologic cancer	1.28e-05	4.46e-05	CcSEcCtD
Zolpidem—Feeling abnormal—Epirubicin—hematologic cancer	1.27e-05	4.46e-05	CcSEcCtD
Zolpidem—Somnolence—Doxorubicin—hematologic cancer	1.27e-05	4.45e-05	CcSEcCtD
Zolpidem—Gastrointestinal pain—Epirubicin—hematologic cancer	1.26e-05	4.43e-05	CcSEcCtD
Zolpidem—Dyspepsia—Doxorubicin—hematologic cancer	1.26e-05	4.41e-05	CcSEcCtD
Zolpidem—Vomiting—Prednisone—hematologic cancer	1.26e-05	4.4e-05	CcSEcCtD
Zolpidem—Rash—Prednisone—hematologic cancer	1.25e-05	4.36e-05	CcSEcCtD
Zolpidem—Dermatitis—Prednisone—hematologic cancer	1.25e-05	4.36e-05	CcSEcCtD
Zolpidem—Decreased appetite—Doxorubicin—hematologic cancer	1.24e-05	4.35e-05	CcSEcCtD
Zolpidem—Headache—Prednisone—hematologic cancer	1.24e-05	4.33e-05	CcSEcCtD
Zolpidem—Gastrointestinal disorder—Doxorubicin—hematologic cancer	1.24e-05	4.32e-05	CcSEcCtD
Zolpidem—Fatigue—Doxorubicin—hematologic cancer	1.23e-05	4.32e-05	CcSEcCtD
Zolpidem—Urticaria—Epirubicin—hematologic cancer	1.23e-05	4.3e-05	CcSEcCtD
Zolpidem—Pain—Doxorubicin—hematologic cancer	1.22e-05	4.28e-05	CcSEcCtD
Zolpidem—Constipation—Doxorubicin—hematologic cancer	1.22e-05	4.28e-05	CcSEcCtD
Zolpidem—Body temperature increased—Epirubicin—hematologic cancer	1.22e-05	4.28e-05	CcSEcCtD
Zolpidem—Abdominal pain—Epirubicin—hematologic cancer	1.22e-05	4.28e-05	CcSEcCtD
Zolpidem—Hypersensitivity—Methotrexate—hematologic cancer	1.22e-05	4.26e-05	CcSEcCtD
Zolpidem—Asthenia—Methotrexate—hematologic cancer	1.19e-05	4.15e-05	CcSEcCtD
Zolpidem—Feeling abnormal—Doxorubicin—hematologic cancer	1.18e-05	4.13e-05	CcSEcCtD
Zolpidem—Nausea—Prednisone—hematologic cancer	1.17e-05	4.11e-05	CcSEcCtD
Zolpidem—Gastrointestinal pain—Doxorubicin—hematologic cancer	1.17e-05	4.09e-05	CcSEcCtD
Zolpidem—Pruritus—Methotrexate—hematologic cancer	1.17e-05	4.09e-05	CcSEcCtD
Zolpidem—Hypersensitivity—Epirubicin—hematologic cancer	1.14e-05	3.99e-05	CcSEcCtD
Zolpidem—Urticaria—Doxorubicin—hematologic cancer	1.14e-05	3.98e-05	CcSEcCtD
Zolpidem—Body temperature increased—Doxorubicin—hematologic cancer	1.13e-05	3.96e-05	CcSEcCtD
Zolpidem—Abdominal pain—Doxorubicin—hematologic cancer	1.13e-05	3.96e-05	CcSEcCtD
Zolpidem—Diarrhoea—Methotrexate—hematologic cancer	1.13e-05	3.96e-05	CcSEcCtD
Zolpidem—Asthenia—Epirubicin—hematologic cancer	1.11e-05	3.88e-05	CcSEcCtD
Zolpidem—Pruritus—Epirubicin—hematologic cancer	1.09e-05	3.83e-05	CcSEcCtD
Zolpidem—Dizziness—Methotrexate—hematologic cancer	1.09e-05	3.82e-05	CcSEcCtD
Zolpidem—Diarrhoea—Epirubicin—hematologic cancer	1.06e-05	3.7e-05	CcSEcCtD
Zolpidem—Hypersensitivity—Doxorubicin—hematologic cancer	1.05e-05	3.69e-05	CcSEcCtD
Zolpidem—Vomiting—Methotrexate—hematologic cancer	1.05e-05	3.68e-05	CcSEcCtD
Zolpidem—Rash—Methotrexate—hematologic cancer	1.04e-05	3.65e-05	CcSEcCtD
Zolpidem—Dermatitis—Methotrexate—hematologic cancer	1.04e-05	3.64e-05	CcSEcCtD
Zolpidem—Headache—Methotrexate—hematologic cancer	1.03e-05	3.62e-05	CcSEcCtD
Zolpidem—Asthenia—Doxorubicin—hematologic cancer	1.03e-05	3.59e-05	CcSEcCtD
Zolpidem—Dizziness—Epirubicin—hematologic cancer	1.02e-05	3.58e-05	CcSEcCtD
Zolpidem—Pruritus—Doxorubicin—hematologic cancer	1.01e-05	3.54e-05	CcSEcCtD
Zolpidem—Vomiting—Epirubicin—hematologic cancer	9.83e-06	3.44e-05	CcSEcCtD
Zolpidem—Nausea—Methotrexate—hematologic cancer	9.81e-06	3.43e-05	CcSEcCtD
Zolpidem—Diarrhoea—Doxorubicin—hematologic cancer	9.79e-06	3.43e-05	CcSEcCtD
Zolpidem—Rash—Epirubicin—hematologic cancer	9.75e-06	3.41e-05	CcSEcCtD
Zolpidem—Dermatitis—Epirubicin—hematologic cancer	9.74e-06	3.41e-05	CcSEcCtD
Zolpidem—Headache—Epirubicin—hematologic cancer	9.69e-06	3.39e-05	CcSEcCtD
Zolpidem—Dizziness—Doxorubicin—hematologic cancer	9.46e-06	3.31e-05	CcSEcCtD
Zolpidem—Nausea—Epirubicin—hematologic cancer	9.18e-06	3.21e-05	CcSEcCtD
Zolpidem—Vomiting—Doxorubicin—hematologic cancer	9.1e-06	3.18e-05	CcSEcCtD
Zolpidem—Rash—Doxorubicin—hematologic cancer	9.02e-06	3.16e-05	CcSEcCtD
Zolpidem—Dermatitis—Doxorubicin—hematologic cancer	9.01e-06	3.15e-05	CcSEcCtD
Zolpidem—Headache—Doxorubicin—hematologic cancer	8.96e-06	3.14e-05	CcSEcCtD
Zolpidem—Nausea—Doxorubicin—hematologic cancer	8.5e-06	2.97e-05	CcSEcCtD
Zolpidem—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	5.57e-06	0.00011	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—NUP98—hematologic cancer	5.56e-06	0.00011	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—ARNTL—hematologic cancer	5.55e-06	0.00011	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—UGT1A1—hematologic cancer	5.52e-06	0.000109	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—NCOR1—hematologic cancer	5.52e-06	0.000109	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—GSTM1—hematologic cancer	5.52e-06	0.000109	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—MTAP—hematologic cancer	5.5e-06	0.000108	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—SLC22A1—hematologic cancer	5.42e-06	0.000107	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—CRABP1—hematologic cancer	5.42e-06	0.000107	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—CA9—hematologic cancer	5.4e-06	0.000107	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—ACP5—hematologic cancer	5.4e-06	0.000107	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—ADCY7—hematologic cancer	5.4e-06	0.000107	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—NCOA3—hematologic cancer	5.4e-06	0.000107	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—CRABP1—hematologic cancer	5.37e-06	0.000106	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—SLC22A1—hematologic cancer	5.37e-06	0.000106	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—CD44—hematologic cancer	5.37e-06	0.000106	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—NQO1—hematologic cancer	5.37e-06	0.000106	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—NUP214—hematologic cancer	5.36e-06	0.000106	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—NCOR2—hematologic cancer	5.33e-06	0.000105	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	5.3e-06	0.000105	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—ALOX5—hematologic cancer	5.28e-06	0.000104	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—ABCG2—hematologic cancer	5.25e-06	0.000104	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—MTR—hematologic cancer	5.25e-06	0.000104	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—ALOX5—hematologic cancer	5.23e-06	0.000103	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—ENO2—hematologic cancer	5.15e-06	0.000102	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—NUP98—hematologic cancer	5.11e-06	0.000101	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—CYCS—hematologic cancer	5.08e-06	0.0001	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—IDH1—hematologic cancer	5.08e-06	0.0001	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—NUP98—hematologic cancer	5.07e-06	0.0001	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—HSP90AA1—hematologic cancer	5.05e-06	9.96e-05	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—MTHFR—hematologic cancer	5.03e-06	9.93e-05	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—TXN—hematologic cancer	5.02e-06	9.9e-05	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—ABCC3—hematologic cancer	5.02e-06	9.9e-05	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—GSTO1—hematologic cancer	5.02e-06	9.9e-05	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—GSTT1—hematologic cancer	4.99e-06	9.86e-05	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—ADCY7—hematologic cancer	4.96e-06	9.8e-05	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—NCOA3—hematologic cancer	4.96e-06	9.8e-05	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—NUP214—hematologic cancer	4.93e-06	9.73e-05	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—ADCY7—hematologic cancer	4.92e-06	9.71e-05	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—NCOA3—hematologic cancer	4.92e-06	9.71e-05	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	4.92e-06	9.7e-05	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—SPHK1—hematologic cancer	4.91e-06	9.69e-05	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—FHL2—hematologic cancer	4.9e-06	9.67e-05	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—NUP214—hematologic cancer	4.89e-06	9.64e-05	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—SDC1—hematologic cancer	4.88e-06	9.63e-05	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—MTHFR—hematologic cancer	4.88e-06	9.62e-05	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	4.84e-06	9.54e-05	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—ABCG2—hematologic cancer	4.83e-06	9.53e-05	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—MTR—hematologic cancer	4.83e-06	9.53e-05	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—AGRN—hematologic cancer	4.8e-06	9.48e-05	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—MTR—hematologic cancer	4.79e-06	9.45e-05	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—ABCG2—hematologic cancer	4.79e-06	9.45e-05	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—ENO2—hematologic cancer	4.74e-06	9.35e-05	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—UGT1A1—hematologic cancer	4.72e-06	9.31e-05	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—ENO2—hematologic cancer	4.69e-06	9.26e-05	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	4.66e-06	9.2e-05	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	4.6e-06	9.08e-05	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—GSTT1—hematologic cancer	4.59e-06	9.06e-05	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—CRABP1—hematologic cancer	4.59e-06	9.06e-05	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—SLC22A1—hematologic cancer	4.59e-06	9.06e-05	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—IDH2—hematologic cancer	4.55e-06	8.99e-05	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—HMMR—hematologic cancer	4.55e-06	8.99e-05	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—GSTT1—hematologic cancer	4.55e-06	8.99e-05	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—SDC1—hematologic cancer	4.49e-06	8.86e-05	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	4.48e-06	8.85e-05	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—GSTP1—hematologic cancer	4.48e-06	8.84e-05	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—ALOX5—hematologic cancer	4.47e-06	8.83e-05	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—SDC1—hematologic cancer	4.45e-06	8.78e-05	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	4.4e-06	8.69e-05	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—NUP98—hematologic cancer	4.33e-06	8.55e-05	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	4.3e-06	8.48e-05	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—ARNTL—hematologic cancer	4.28e-06	8.45e-05	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	4.25e-06	8.39e-05	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—ABCB1—hematologic cancer	4.24e-06	8.36e-05	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—PIK3CG—hematologic cancer	4.23e-06	8.34e-05	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—ADCY7—hematologic cancer	4.21e-06	8.3e-05	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—NCOA3—hematologic cancer	4.21e-06	8.3e-05	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	4.2e-06	8.28e-05	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—NUP214—hematologic cancer	4.18e-06	8.24e-05	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—ACP5—hematologic cancer	4.17e-06	8.22e-05	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—CA9—hematologic cancer	4.17e-06	8.22e-05	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—NQO1—hematologic cancer	4.15e-06	8.19e-05	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—CD44—hematologic cancer	4.15e-06	8.19e-05	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	4.13e-06	8.16e-05	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—NCOR1—hematologic cancer	4.11e-06	8.12e-05	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—GSTM1—hematologic cancer	4.11e-06	8.12e-05	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—NCOR2—hematologic cancer	4.11e-06	8.11e-05	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—PIK3CG—hematologic cancer	4.1e-06	8.08e-05	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—ABCG2—hematologic cancer	4.09e-06	8.07e-05	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—MTR—hematologic cancer	4.09e-06	8.07e-05	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	4.06e-06	8.02e-05	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	4.01e-06	7.92e-05	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—ENO2—hematologic cancer	4.01e-06	7.92e-05	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—CYCS—hematologic cancer	3.93e-06	7.75e-05	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—CREBBP—hematologic cancer	3.92e-06	7.73e-05	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—IDH1—hematologic cancer	3.92e-06	7.73e-05	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—HSP90AA1—hematologic cancer	3.9e-06	7.7e-05	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—GSTT1—hematologic cancer	3.89e-06	7.68e-05	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—TXN—hematologic cancer	3.87e-06	7.64e-05	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—GSTO1—hematologic cancer	3.87e-06	7.64e-05	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—ABCC3—hematologic cancer	3.87e-06	7.64e-05	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	3.83e-06	7.56e-05	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—NQO1—hematologic cancer	3.82e-06	7.53e-05	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—CD44—hematologic cancer	3.82e-06	7.53e-05	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—SDC1—hematologic cancer	3.8e-06	7.51e-05	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—CREBBP—hematologic cancer	3.8e-06	7.5e-05	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—SPHK1—hematologic cancer	3.79e-06	7.48e-05	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—CD44—hematologic cancer	3.78e-06	7.47e-05	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—NQO1—hematologic cancer	3.78e-06	7.47e-05	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—PIK3CD—hematologic cancer	3.72e-06	7.33e-05	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	3.71e-06	7.31e-05	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—ALB—hematologic cancer	3.67e-06	7.24e-05	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—UGT1A1—hematologic cancer	3.64e-06	7.19e-05	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—MTHFR—hematologic cancer	3.64e-06	7.18e-05	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	3.63e-06	7.17e-05	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—CYCS—hematologic cancer	3.61e-06	7.13e-05	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—PIK3CD—hematologic cancer	3.6e-06	7.11e-05	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—HSP90AA1—hematologic cancer	3.59e-06	7.08e-05	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	3.59e-06	7.08e-05	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—CYCS—hematologic cancer	3.58e-06	7.07e-05	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—HSP90AA1—hematologic cancer	3.56e-06	7.02e-05	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—ALB—hematologic cancer	3.56e-06	7.02e-05	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—SLC22A1—hematologic cancer	3.54e-06	6.99e-05	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—CRABP1—hematologic cancer	3.54e-06	6.99e-05	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	3.51e-06	6.93e-05	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—PIK3R1—hematologic cancer	3.51e-06	6.92e-05	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—GSTP1—hematologic cancer	3.46e-06	6.83e-05	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—ALOX5—hematologic cancer	3.45e-06	6.81e-05	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	3.43e-06	6.77e-05	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—PIK3R1—hematologic cancer	3.4e-06	6.71e-05	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	3.35e-06	6.61e-05	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—NUP98—hematologic cancer	3.34e-06	6.6e-05	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—ABCB1—hematologic cancer	3.28e-06	6.47e-05	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—ADCY7—hematologic cancer	3.25e-06	6.4e-05	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—NCOA3—hematologic cancer	3.25e-06	6.4e-05	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—PIK3CB—hematologic cancer	3.24e-06	6.39e-05	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—NQO1—hematologic cancer	3.23e-06	6.38e-05	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—CD44—hematologic cancer	3.23e-06	6.38e-05	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—NUP214—hematologic cancer	3.22e-06	6.36e-05	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	3.2e-06	6.32e-05	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—GSTP1—hematologic cancer	3.18e-06	6.28e-05	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—NCOR1—hematologic cancer	3.18e-06	6.28e-05	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—GSTM1—hematologic cancer	3.18e-06	6.28e-05	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	3.17e-06	6.25e-05	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—MTR—hematologic cancer	3.16e-06	6.23e-05	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—ABCG2—hematologic cancer	3.16e-06	6.23e-05	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—GSTP1—hematologic cancer	3.16e-06	6.23e-05	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—PIK3CB—hematologic cancer	3.14e-06	6.19e-05	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—ENO2—hematologic cancer	3.1e-06	6.11e-05	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—CYCS—hematologic cancer	3.06e-06	6.04e-05	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—PIK3CG—hematologic cancer	3.06e-06	6.03e-05	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	3.05e-06	6.03e-05	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—HSP90AA1—hematologic cancer	3.04e-06	6e-05	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—ABCB1—hematologic cancer	3.01e-06	5.95e-05	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—GSTT1—hematologic cancer	3e-06	5.93e-05	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—ABCB1—hematologic cancer	2.99e-06	5.9e-05	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—SDC1—hematologic cancer	2.94e-06	5.79e-05	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—GSTM1—hematologic cancer	2.93e-06	5.77e-05	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—NCOR1—hematologic cancer	2.93e-06	5.77e-05	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—GSTM1—hematologic cancer	2.9e-06	5.72e-05	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—NCOR1—hematologic cancer	2.9e-06	5.72e-05	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—CREBBP—hematologic cancer	2.83e-06	5.59e-05	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—MTHFR—hematologic cancer	2.81e-06	5.55e-05	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—PTEN—hematologic cancer	2.8e-06	5.52e-05	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	2.74e-06	5.4e-05	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—PTEN—hematologic cancer	2.71e-06	5.35e-05	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—GSTP1—hematologic cancer	2.7e-06	5.32e-05	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—PIK3CD—hematologic cancer	2.69e-06	5.3e-05	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—EP300—hematologic cancer	2.67e-06	5.27e-05	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—ALB—hematologic cancer	2.65e-06	5.23e-05	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.61e-06	5.15e-05	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—EP300—hematologic cancer	2.59e-06	5.11e-05	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—MTHFR—hematologic cancer	2.59e-06	5.1e-05	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—MTHFR—hematologic cancer	2.56e-06	5.06e-05	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—ABCB1—hematologic cancer	2.55e-06	5.04e-05	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—PIK3R1—hematologic cancer	2.54e-06	5e-05	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—CD44—hematologic cancer	2.5e-06	4.93e-05	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—NQO1—hematologic cancer	2.5e-06	4.93e-05	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—GSTM1—hematologic cancer	2.48e-06	4.89e-05	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—NCOR1—hematologic cancer	2.48e-06	4.89e-05	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.48e-06	4.89e-05	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—PIK3CG—hematologic cancer	2.36e-06	4.66e-05	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—CYCS—hematologic cancer	2.36e-06	4.66e-05	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	2.35e-06	4.63e-05	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—PIK3CB—hematologic cancer	2.34e-06	4.62e-05	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.26e-06	4.46e-05	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—MTHFR—hematologic cancer	2.19e-06	4.32e-05	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—CREBBP—hematologic cancer	2.19e-06	4.32e-05	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—PIK3CG—hematologic cancer	2.17e-06	4.29e-05	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—PIK3CG—hematologic cancer	2.15e-06	4.25e-05	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—GSTP1—hematologic cancer	2.08e-06	4.11e-05	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—PIK3CD—hematologic cancer	2.08e-06	4.1e-05	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—ALB—hematologic cancer	2.05e-06	4.05e-05	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—PTEN—hematologic cancer	2.02e-06	3.99e-05	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—CREBBP—hematologic cancer	2.01e-06	3.97e-05	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—CREBBP—hematologic cancer	2e-06	3.94e-05	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—PIK3CA—hematologic cancer	1.97e-06	3.9e-05	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—ABCB1—hematologic cancer	1.97e-06	3.89e-05	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—PIK3R1—hematologic cancer	1.96e-06	3.87e-05	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.93e-06	3.81e-05	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—EP300—hematologic cancer	1.93e-06	3.81e-05	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—PIK3CA—hematologic cancer	1.91e-06	3.78e-05	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—NCOR1—hematologic cancer	1.91e-06	3.77e-05	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—GSTM1—hematologic cancer	1.91e-06	3.77e-05	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—PIK3CD—hematologic cancer	1.91e-06	3.77e-05	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—PIK3CD—hematologic cancer	1.89e-06	3.74e-05	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—ALB—hematologic cancer	1.89e-06	3.72e-05	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—ALB—hematologic cancer	1.87e-06	3.69e-05	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—PIK3CG—hematologic cancer	1.84e-06	3.63e-05	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—PIK3CB—hematologic cancer	1.81e-06	3.57e-05	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—PIK3R1—hematologic cancer	1.8e-06	3.56e-05	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—PIK3R1—hematologic cancer	1.79e-06	3.53e-05	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—CREBBP—hematologic cancer	1.71e-06	3.37e-05	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—MTHFR—hematologic cancer	1.69e-06	3.34e-05	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—PIK3CB—hematologic cancer	1.66e-06	3.29e-05	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—PIK3CB—hematologic cancer	1.65e-06	3.26e-05	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—PIK3CD—hematologic cancer	1.62e-06	3.19e-05	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—AKT1—hematologic cancer	1.61e-06	3.18e-05	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—ALB—hematologic cancer	1.6e-06	3.15e-05	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—PTEN—hematologic cancer	1.56e-06	3.09e-05	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—AKT1—hematologic cancer	1.56e-06	3.08e-05	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—PIK3R1—hematologic cancer	1.53e-06	3.01e-05	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—EP300—hematologic cancer	1.49e-06	2.94e-05	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—PTEN—hematologic cancer	1.44e-06	2.84e-05	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—PIK3CA—hematologic cancer	1.43e-06	2.82e-05	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—PTEN—hematologic cancer	1.43e-06	2.81e-05	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—PIK3CG—hematologic cancer	1.42e-06	2.8e-05	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—PIK3CB—hematologic cancer	1.41e-06	2.78e-05	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—EP300—hematologic cancer	1.37e-06	2.71e-05	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—EP300—hematologic cancer	1.36e-06	2.68e-05	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—CREBBP—hematologic cancer	1.32e-06	2.6e-05	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—PIK3CD—hematologic cancer	1.25e-06	2.46e-05	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—ALB—hematologic cancer	1.23e-06	2.43e-05	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—PTEN—hematologic cancer	1.22e-06	2.4e-05	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—PIK3R1—hematologic cancer	1.18e-06	2.33e-05	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—AKT1—hematologic cancer	1.17e-06	2.3e-05	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—EP300—hematologic cancer	1.16e-06	2.29e-05	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—PIK3CA—hematologic cancer	1.1e-06	2.18e-05	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—PIK3CB—hematologic cancer	1.09e-06	2.15e-05	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—PIK3CA—hematologic cancer	1.01e-06	2e-05	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—PIK3CA—hematologic cancer	1.01e-06	1.99e-05	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—PTEN—hematologic cancer	9.4e-07	1.86e-05	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—AKT1—hematologic cancer	9.01e-07	1.78e-05	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—EP300—hematologic cancer	8.97e-07	1.77e-05	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—PIK3CA—hematologic cancer	8.6e-07	1.7e-05	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—AKT1—hematologic cancer	8.29e-07	1.64e-05	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—AKT1—hematologic cancer	8.22e-07	1.62e-05	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—AKT1—hematologic cancer	7.02e-07	1.39e-05	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—PIK3CA—hematologic cancer	6.63e-07	1.31e-05	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—AKT1—hematologic cancer	5.42e-07	1.07e-05	CbGpPWpGaD
